Literature DB >> 18274621

Reduced white fat mass in adult mice bearing a truncated Patched 1.

Zili Li1, Heng Zhang, Leslie A Denhard, Lan-Hsin Liu, Huaxin Zhou, Zi-Jian Lan.   

Abstract

Hedgehog (Hh) signaling emerges as a potential pathway contributing to fat formation during postnatal development. In this report, we found that Patched 1 (Ptc1), a negative regulator of Hh signaling, was expressed in the epididymal fat pad of adult mice. Reduced total white fat mass and epididymal adipocyte cell size were observed in naturally occurring spontaneous mesenchymal dysplasia (mes) adult mice (Ptc1(mes/mes)), which carry a deletion of Ptc1 at the carboxyl-terminal cytoplasmic region. Increased expression of truncated Ptc1, Ptc2 and Gli1, the indicators of ectopic activation of Hh signaling, was observed in epididymal fat pads of adult Ptc1(mes/mes) mice. In contrast, expression of peroxisome proliferator-activated receptor gamma, CCAAT/enhancer binding protein alpha, adipocyte P2 and adipsin were reduced in epididymal fat pads of adult Ptc1(mes/mes) mice. Taken together, our results indicate that deletion of carboxyl-terminal tail of Ptc1 can lead to the reduction of white fat mass during postnatal development.

Entities:  

Keywords:  Patched 1; body weight; gene expression; mouse; spontaneous mesenchymal dysplasia; white fat mass

Mesh:

Substances:

Year:  2008        PMID: 18274621      PMCID: PMC2238183          DOI: 10.7150/ijbs.4.29

Source DB:  PubMed          Journal:  Int J Biol Sci        ISSN: 1449-2288            Impact factor:   6.580


Introduction

Hedgehog (Hh) signaling plays a critical role during embryonic development and tumorigenesis 1, 2. The canonical Hh signaling cascade is initiated through the binding of secreted Hh proteins to the membrane-bound receptor Patched-1 (Ptc1) or Patched-2 (Ptc2) to relieve patched-mediated repression of the signal transducer smoothened (Smo), leading to the activation of transcription factors Gli1, Gli2 and Gli3 to enhance transcription of downstream targets such as Ptc1, Ptc2 and Gli1 1-5. In addition to its critical roles during embryonic development and tumorigenesis, Hh signaling emerges as a potential mediator of fat formation and body weight gain during postnatal development 6, 7. Injection of adult mice with sonic Hh (Shh)-IgG fusion protein (a Hh agonist) causes a significant increase in fat mass and body weight without affecting food consumption and fluid intake 8. In agreement with this observation, inactivation of Hh signaling by injection of anti-Hh antibodies in normal adult mice fed with a high-fat diet and in obese leptin-deficient (ob/ob) mice fed with a low-fat diet can significantly reduce body weight gain in these animals 9. These animal studies suggest that Hh signaling may stimulate fat formation (adipogenesis) and promote body weight gain in adult mice 8, 9. In contrast to the above animal studies 8, 9, it has been reported that Hh can block adipogenesis in cultured mammalian adipocytic or multipotent mesenchymal cells 10-13. This is highlighted by the recent study by Suh et al 13. They found that fat-body-specific activation of Hh signaling inhibited fat formation in Drosophila and that Hh blocked adipogenesis in mammalian cells by regulating antiadipogenic gene expression. In addition, they found that Hh signaling molecules such as Gli1, Gli2 and Gli3 are expressed in white fat tissues (WAT) of adult mice and that expression of these genes are down-regulated in normal mice fed with high fat diet and in ob/ob mice. A model of Hh signaling in inhibiting fat formation has been proposed in which Hh activates Gli transcription factors (Gli1, Gli2 and Gli3), which then activate antiadipogenic gene expression to inhibit the expression of adipogenic genes such as peroxisome proliferator-activated receptor gamma (PPARgamma) 14, 15 and CCAAT/enhancer binding protein alpha (CEBPalpha) 16 in adipose tissues, resulting in inhibition of adipogenesis 6, 13. According to this model, it is expected that ectopic activation of Hh signaling in adipose tissues will reduce fat formation in adults, which would be contradictory to observations reported by Martin et al 8. Therefore, whether Hh signaling acts to stimulate or inhibit fat formation during postnatal development remains to be characterized in vivo using animal models such as mutant mice carrying deletions of Hh signaling molecules. Ptc1 is a negative regulator of the Hh signaling during embryonic development 1, 4. It is a Hh receptor protein containing twelve transmembrane domains and intracellular amino- and carboxyl-terminal regions 2, 17. In the absence of Hh, Ptc1 represses Smo activity. This repression of Smo is relieved once after Hh binds to the extracellular loops within the transmembrane domains of Ptc1, resulting in the activation of Hh signaling downstream target genes to elicit its biological functions 2, 5, 17, 18. It have been shown that the carboxyl terminus of Ptc1 is important for the inactivation of Hh signaling target genes and the localization and degradation of Ptc1 itself 19, 20. Deletion of Ptc1 in mice can mimic ectopic Hh signaling and cause embryonic lethality, indicating the essential role of Ptc1 during embryonic development 21. Although Ptc1 has been shown to be a determinant of body weight in utero 21-23, there is no direct evidence that Ptc1 is also involved in controlling fat formation during postnatal development. The naturally occurring spontaneous mesenchymal dysplasia (mes) mouse line (Ptc1), which has a deletion of the Ptc1 protein at the carboxyl-terminal cytoplasmic region and can bypass the embryonic lethality observed in a complete knockout of Ptc1 22, 24, would be an excellent model to investigate the potential role of Ptc1 in fat formation during postnatal development. In this communication, we found that Ptc1 was expressed in epididymal white fat tissue (WAT) in adult mice. Loss of the carboxyl-terminus of Ptc1 in adult Ptc1mice caused a significant reduction in WAT. The adipocyte size of epididymal WAT was also reduced in Ptc1 mice. Gene expression analyses showed that truncated Ptc1, Ptc2 and Gli1 were overexpressed in WAT of Ptc1 mice, indicating ectopic activation of Hh signaling in WAT. Consistent with reduced WAT, expression of adipogenic genes, PPARgamma and CEBPalpha, and the adipocyte marker genes, adipocyte P2 (aP2) 25 and adipsin 26, were reduced in WAT of adult Ptc1 males. Collectively, our results suggest that Ptc1 play a role in white fat formation during postnatal development. This study supports earlier findings of Suh et al and Spinella-Jaegle et al that Hh signaling inhibits fat formation in cultured cells 10, 13.

Materials and Methods

Animals and genotyping

Ptc1mes/+ mice (B6C3Fe-a/a strain) were purchased from the Jackson Laboratory (Bar Harbor, Maine, USA) and maintained on a 14 hour light:10 hour dark cycle, with free access to normal chow (Lab diet, Catalog #5001, USA) and water, in the vivarium of the University of Louisville. Ptc1, Ptc1 and Ptc1littermates were obtained from the intercross of Ptc1mice and genotyped as previously described 22.

Tissue collection and body, tissue and total WAT weight analyses

Mice at various ages were euthanized with carbon dioxide and the body weights of these mice were determined using an electronic balance. Liver, spleen, kidney, lung, heart and total WAT including subcutaneous, abdominal and intra-scapular fat in mice were collected and weighed using a balance. Since it took some time to collect WAT from subcutaneous regions of the whole animal which may damage the WAT histology and cause RNA degradation, WAT from epididymides were quickly harvested for histological and RNA analyses.

Histological analysis of WAT and determination of WAT size

Epididymal WAT was fixed in 4% paraformaldehyde, dehydrated and then embedded in paraffin. The paraffin-embedded tissues were sectioned at 7 μm thickness, stained with hematoxylin and eosin, and then examined under a microscope (Axioskop2, Zeiss, Thornwood, NY, USA). The average size of adipocyte cells from each mouse was determined by analyzing 40 randomly-selected adipocyte cells from 20 sections using the Zeiss Imaging Quantitative Software (Zeiss, Thornwood, NY, USA).

RNA isolation and RT-PCR

RNA was isolated from epididymal WAT of Ptc1mes/mes and control mice using Trizol reagent (Invitrogen, Carlsbad, CA , USA). First strand cDNA was synthesized at 42oC for 60 min using 1 μg of total RNA as template and random hexanucleotides as primers (Promega, Madison, WI, USA). PCR reactions with 1/10 of the cDNA were carried out in a buffer containing 1.5 mM MgCl2 (94oC, 1 min; 52oC, 1 min; 72oC 1 min) for various numbers of PCR cycles (20-38 cycles), which can detect the differential gene expression (within the linear range of PCR products for each gene). The nucleotide sequences of PCR primers are as follows: Ptc1 (Ptc1-F: 5'-tgtctggcatcagtgaggag-3', Ptc1-R: 5'-gacaaggagccagagtccag-3', 190 bp; Ptc1-F2: 5'-gctggaggagaacaagcaac-3', Ptc1-R2: 5'-cattggggtagctggacagt-3', 536 bp), Ptc2 (5'-tgcctctctggagggcttcc-3' and 5'-cagttcctcctgccagtgca-3', 208 bp), Gli1 (5'-actggggtgagttcccttct-3' and 5'-tggcagggctctgactaact-3', 492 bp), Gli2 (5'-ccccctagcatcaatgagaa-3' and 5'-tctgcacggattgtggatta-3', 496 bp), Gli3 (5'-ctacggcgactgagaggaag-3' and 5'- tggcatcaattggtacagga-3', 396 bp), glucocorticoid-induced leucine-zipper protein (Gilz, 5'-tggggcctagtaacaccaag-3' and 5'-aagctgtaaccccacactgg-3', 364 bp), CEBPalpha (5'-atcccagagggactggagtt-3' and 5'-aagtcttagccggaggaagc-3', 373 bp), PARgamma (5'- ccctggcaaagcatttgtat-3' and 5'-aatccttggccctctgagat-3', 403 bp), aP2 (5'- tcacctggaagacagctcct-3' and 5'-tcgactttccatcccacttc-3', 344 bp), adipsin (5'-caagcgatggtatgatgtgc-3' and 5'-atccggtaggatgacactcg-3', 465 bp) and beta-actin (5'-ttgagaccttcaacacccc-3' and 5'-agccagagcagtaatctcc-3', 593 bp). All PCR products were confirmed by DNA sequencing.

Food intake measurement

Five adult wild type and Ptc1 mice at the age of 23-27 weeks were singly housed with free access to water. The food present in a sealed food hooper was recorded weekly for consecutive two weeks using an electronic balance.

Glucose tolerance test

Glucose tolerance test was performed as described previously 23. Briefly, overnight-fasted 24-26-week-old wild type, heterozygous and homozygous Ptc1 littermates were injected intraperitoneally with 2 grams/kg body weight of 20% D-glucose. Blood glucose levels at time 0 (immediately before the injection of glucose), 15, 30, 60, 120 and 180 minutes after injection of glucose were determined using a Glucometer Elite glucometer.

Statistical analysis

When applicable, Student's t-test was used to determine the statistical significance of difference between Ptc1mes/mes and control littermates with P value less than 0.05. Data are presented as mean ± SEM of indicated numbers of mice in the figures.

Results

Expression of Hh signaling molecules Ptc1, Ptc2, Gli1, Gli2 and Gli3 in WAT of adult mice

To determine whether Hh signaling molecules such as Ptc1, Ptc2, Gli1, Gli2 and Gli3 are expressed in WAT of adult mice, we performed RT-PCR analyses using specific primers for each gene. As shown in Figure 1, specific PCR products for those genes were detected in RNA samples from epididymal WAT of adult mice. In addition, we also observed the expression of an antiadipogenic gene Gilz 27, adipogenic genes CEBPalpha and PPARgamma, and mature adipocyte marker genes aP2 and adipsin in epididymal WAT (Figure 1).
Figure 1

Expression of Ptc1, Ptc2, Gli1 Gli2 and Gli3 in mouse epididymal WAT. Epididymal WAT RNA from 8-week-old mice was subjected to RT-PCR analyses using specific primers for Ptc1 (Ptc1-F and Ptc1-R), Ptc2, Gli1, Gli2, Gli3, Gilz, PPARgamma, CEBPalpha, aP2 and adipsin. The numbers of PCR reaction cycles are 36 for Ptc1, 38 for Ptc2 and 32 for other tested genes. Water was included as negative controls.

Reduced total WAT and adipocyte cell size in adult Ptc1 mice

To investigate if there is any defect in WAT during postnatal development, total WAT, body and major organ weights of male Ptc1, Ptc1 and Ptc1 littermates at various ages were determined (Figure 2). As shown in Figure 2a, total WAT weights were reduced in Ptc1 male mice during postnatal development with a modest reduction at the age of 19-20 weeks and the remarkable reduction at the age of 33 or 38 weeks, when compared to their wild type and heterozygous littermates (Figure 2a). No significant changes in body weights were observed between male Ptc1and control wild type and heterozygous littermates during postnatal development, except that 19-20-week-old Ptc1males were slightly heavier than their controls (Figure 2b). The ratios of total WAT to body weights were also significantly reduced in 19-20-week-old or older Ptc1 males (Figure 2c). In contrast, there were no significant changes in gross weights of other tested organs including liver, spleen, kidney, lung and heart (Figure 2d). The representative results of reduced total WAT of 33-week-old Ptc1male mice were shown in Figure 2e. Histological analyses showed that epididymal fat cells of these Ptc1mice were smaller than those of Ptc1mice (Figure 2f). Quantitative analyses showed that the sizes of epididymal WAT cells in 33-week-old Ptc1mice were significantly reduced (P < 0.01), when compared to those of Ptc1littermates (Figure 2g).
Figure 2

Reduced total WAT and adipocyte cell sizes in adult male Ptc1mice, when compared to control Ptc1 littermates. a-d. Total WAT weights (a), body weights (b), the ratios of total WAT to body weights (c) and major organ weights (d) of Ptc1, Ptc1 and Ptc1 male mice during postnatal development. e. Representative photos showing reduced total WAT in Ptc1mice. Total WAT of two wild type and their Ptc1 littermates at the age of 33 weeks are shown. f. Histology of WAT from 33-week-old Ptc1 and Ptc1 littermates. Note the small adipocyte cell size in WAT of Ptc1 mice. g. Quantitative analyses showing the reduced cell size of WAT in 33-week-old Ptc1 mice, when compared to their wild type littermates. In a-d and g, data are presented as mean ± SEM of the indicated numbers of mice in the bar graphs. *P < 0.05, **P < 0.01, when compared to Ptc1+/+ and/or Ptc1littermates.

Enhanced expression of Hh signaling target genes (amino region of Ptc1, Ptc2, and Gli1) and reduced expression of adipogenic genes PPARgamma and CEBPalpha as well as adipocyte marker genes aP2 and adipsin in epididymal WAT of adult Ptc1mes/mes mice

It has been reported that Ptc1mutant mice carry a deletion of a 32 bp DNA fragment in the exon 22 of Ptc1 allele 22 (Figure 3a). To confirm this, we isolated RNA from epididymal WAT of 8-10-week-old wild type and Ptc1 mice and performed RT-PCR analyses. As shown in Figure 3a, a positive DNA band covering exons 22 and 23 (using Ptc1-F and Ptc1-R primers) was detected in wild type, but not Ptc1mice. These results confirmed the absence of the carboxyl-terminus of Ptc1 mRNA in epididymal WAT of Ptc1 mice. Since Ptc1 is a known downstream target gene of Hh signaling, RT-PCR analyses were also performed to determine whether expression of the amino region of the Ptc1 gene will be upregulated in epididymal WAT of Ptc1 mice. As shown Figure 3a, positive DNA bands covering exons 15 and 18 of Ptc1 (using Ptc1-F2 and Ptc1-R2 primers) were detected in wild type mice and even more pronounced in Ptc1 mice. Similar Ptc1 expression patterns were observed in epididymal WAT from 33-week-old mice (Figure 3b), indicating that the amino-terminal Ptc1 mRNA is overexpressed in WAT of Ptc1mice.
Figure 3

Increased expression of Ptc1, Ptc2, Gli1 and Gli2 and reduced expression of PPARgamma, CEBPalpha, aP2 and adipsin in epididymal WAT of Ptc1mice. a. Representative RT-PCR analyses showing the loss of carboxyl-terminal Ptc1 mRNA (using Ptc1-F and Ptc1-R primers, 36 cycles) and increased expression of amino-terminal Ptc1 mRNA (using Ptc1-F2 and Ptc1-R2 primers, 32 cycles) in WAT of two 8-10-week-old Ptc1mice. Deletion of 32 bp coding sequence within the exon 22 of Ptc1 in Ptc1 mice is highlighted by a yellow box. Two sets of RT-PCR primers for Ptc1 mRNA are indicated by arrows. b. Representative semi-quantitative RT-PCR showing the increased expression of amino-terminal Ptc1, Ptc2, Gli1 and Gli2 and the reduced expression of PPARgamma, CEBPalpha, aP2 and adipsin in epididymal WAT of 33-week-old Ptc1 mice. The numbers of PCR reaction cycles for carboxyl-terminal Ptc1 [Ptc1 (C): using primers Ptc1-F and Ptc1-R], amino-terminal Ptc1 [Ptc1-(N):using primers Ptc1-F2 and Ptc1-R2], Ptc2, Gli1, Gli2, Gli3, Gilz, CEBPalpha, PPARgamma, aP2, adipsin and beta-actin were 36, 38, 38, 26, 26, 38, 36, 28, 28, 20, 20 and 32, respectively. Experiments were repeated twice on independent RNA samples.

To determine whether there is mis-expression of other Hh signaling molecules and WAT marker genes in epididymal WAT, semi-quantitative RT-PCR analyses were performed on RNA samples isolated from 33-week-old Ptc1 mice. As shown in Figure 3b, expression levels of the Hh signaling downstream target genes Ptc1, Ptc2 and Gli1were increased in epididymal WAT of Ptc1mice, when compared to those of Ptc1 mice. Expression of Gli2, but not Gli3, was also increased in epididymal WAT of Ptc1mice. In contrast, reduced expression of PPARgamma and CEBPalpha, two known adipogenic genes, were observed in Ptc1mice, while there was no obvious change in the expression level of Gilz, an antiadipogenic gene 27, between Ptc1and Ptc1mice (Figure 3b). In addition, expression of WAT marker genes aP2 and adipsin were also reduced in Ptc1 mice (Figure 3b).

No significant changes in food consumption and glucose tolerance in adult Ptc1 mice

To determine if there is any difference in food consumption by Ptc1and their control Ptc1 mice, we performed food intake experiments. As shown in Figure 4a, there was no statistically significant change in food consumption in either adult Ptc1 or Ptc1 mice during the consecutive two weeks. The average food intake by adult Ptc1 mice at each tested week was also not significantly different from Ptc1 control mice (Figure 4a). To test if there is any abnormality in serum glucose concentrations in adult Ptc1 mice, glucose tolerance experiments were performed. As shown in Figure 4b, no statistical significance of difference in serum glucose concentrations among adult Ptc1, Ptc1 and Ptc1 mice at each tested time point after the injections of high doses of glucose.
Figure 4

No significant change in (a) food intake and (b) glucose tolerance between adult Ptc1and their control (Ptc1 or Ptc1) mice. a. Food consumption by five adult wild type and Ptc1 mice at the age of 23-27 weeks was recorded weekly for consecutive two weeks. b. Overnight-fasted 24-26-week-old littermates were subjected to glucose tolerance experiments as described in Materials and Methods. Data are presented as mean ± SEM of the indicated numbers of mice in the bar graphs. Student's t-test was performed to determine the significant difference. P value was greater than 0.05 between Ptc1 and controls (Ptc1 or Ptc1) at each time point in the figure.

Discussion

In our ongoing study to determine the role of Ptc during ovarian and uterine development in Ptc mice, we observed that total white fat masses in adult female Ptcmice were less than their wild type littermates (unpublished data). Since female Ptcmice are being used to characterize their ovarian and uterine phenotypes, male Ptcand their control littermates were used to investigate the potential defects in WAT during postnatal development in this report. We found that Ptc1 was expressed in adult WAT and that loss of the carboxyl-terminus of Ptc1 in adult mice caused a significant reduction in total white fat mass and adipocyte cell size (Figure 1-2). Reduced white fat mass observed in adult Ptc1mice can be due to the reduced cell sizes of adipocyte cells (Figure 2) and the reduced adipocyte cell numbers in adult Ptc1mice. The latter is indicated by the observation that the reduced levels of adipose cell sizes (40% of controls) are less than the reduced levels of total WAT weights in 33-week-old Ptc1(about 75% of controls), even though it is difficult and almost impossible to determine the exact numbers of total adipocyte cells in adult mice. Since we did not observe significant changes in food intake and blood glucose concentrations in adult Ptc1mice (Figure 4), the reduced white fat mass (reduced adipocyte cell size and cell numbers) is probably not due to reduced food consumption and aberrant glucose metabolism observed in Ptc1mice 28 as well as other hormonal signaling such as insulin signaling during adipogenesis 29. Rather, the reduced white fat mass is likely due to the defective Hh signaling during adipogenesis in Ptc1mice during postnatal development. By RT-PCR analyses, we found that many Hh signaling molecules are expressed in epididymal WAT (Figure 1), which is consistent with the presence of Gli transcription factors in perigonadal fat pads reported previously 13. Importantly, we found that truncated Ptc1, Ptc2 and Gli1, the Hh signaling downstream target genes, are overexpressed in epididymal WAT of Ptc1 mice (Figure 3b), indicating the ectopic activation of Hh signaling in WAT to regulate its downstream gene expression for fat formation. Consistent with reduced white fat mass in Ptc1mes/mes mice, we also observed the reduced expression of adipocyte marker genes aP2 and adipsin. These reduced expression of adipocyte marker genes likely results from the decreased expression of adipogenic genes PPARgamma and CEBPalpha. It has been reported that Shh can inhibit adipocyte differentiation in 3T3-L1 cells, C3H10T1/2 and primary mouse calvaria cells 10, 13. Overexpression of Gli1 and reduced expression of adipocyte markers, aP2 and/or adipsin, and adipogenic transcription factors, PPARgamma and CEBPalpha, have been observed in Shh-treated 3T3-L1 or C3H10T1/2 cells 10, 13. Moreover, reduced expression of Gli1 and Gli2 has been reported in ob/ob mice and normal mice fed with a high fat diet to induce obesity 13. Collectively, our results are consistent with the recent findings from cultured cells 10, 13, indicating that Hh signaling plays a role in inhibiting WAT formation in adult mice. Since we did not observe overexpression of Gilz, an antiadipogenic gene, which has been reported by Suh et al in cultured cells 13, it is likely that the action of Hh signaling in adult white fat formation is via the inhibition of adipogenic gene transcription, rather than the stimulation of antiadipogenic gene expression. Our gene expression results indicate that Gli1 and Gli2, but not Gli3, may be two major transcription factors involved in adult WAT formation. These Gli transcription factors may inhibit transcription of adipogenic genes PPARgamma and CEBPalpha in adipocyte cells, resulting in reduced WAT formation. Or, they could directly regulate adipocyte gene expression such as aP2 in WAT, given that Gli1 can inhibit aP2 promoter activity in C3H10T1/2 cells 10. Future studies using molecular approaches such as gel-shift mobility and promoter reporter analyses will determine these possibilities. In addition, further molecular analyses of Hh signaling downstream genes in Hh agonist- or antagonist-treated 3T3-L1 cells over-expressing the amino region of Ptc1 (with a deletion of C-terminal residues of Ptc1) or mouse embryonic fibroblast cells isolated from Ptc1 embryos will likely provide more details about the mechanism about the action of C-terminal tail of Ptc1 during adipogenesis. We observed that there was a gradual reduction of total WAT in Ptc1males during postnatal development with no significant reduction of total WAT weights at the age of 5-6 weeks, modest reduction in 19-20-week-old mice and remarkable reduction in 33-week-old or older mice. This gradual reduction of WAT observed in our studies is contradictory to the previous finding of the increased adipose weights in Shh-treated mice 8. One possible reason may be due to the differential expression levels of Hh target genes such as Ptc1, Ptc2 and Gli1 in white adipocyte cells in mice during postnatal development. Future gene expression analyses of Ptc1 mice at different developmental stages and Shh agonist-treated mice will be required to address this possibility. Increased body weights have been observed in Ptc1 mutant embryos 21-23 and Shh-treated normal mice 8. Inhibition of body weight gain has also been reported in mice injected with antibodies against Hh proteins 9. Ectopic activation of Hh signaling in Ptc1mice would lead to general stimulation of cell proliferation (other than adipocyte cells), resulting in an increase of body weight. However, we did not observe a significant increase of the body weight in Ptc1mice during postnatal development, except those mice at the age of 19-20 weeks after birth (Figure 2). This phenomena is unlikely due to the reduction of food consumption as well as potential aberrant glucose metabolism displayed in Ptc1mice 28, since food consumption and serum glucose levels in adult Ptc1mice appears to be comparable with those of control littermates (Figure 4). Considering that the major organ weights including liver, heart, kidney, lung and spleen were not significantly different between Ptc1and their control mice (Figure 2d), it is also unlikely the case that the general stimulation of cell proliferation by Hh signaling observed in embryos 22 plays a significant role in body weight gain during postnatal development. Instead, Hh signaling may be active only in a subset of target tissues such as WAT to elicit its biological function in adult Ptc1mice. Interestingly, Ptc1 mice at the age of 33 weeks or older were not lighter than their control littermates, even though there was a significant reduction of total white fat mass (Figure 2). In light of no significant changes in major organ weights in Ptc1mice, it is possible that hyperplasia in other tissues and/or cells other than WAT and tested organs exist in Ptc1 mice, which may offset the reduced WAT weights. In support of this, we did notice that Ptc1mice at that age appear to be rounder and bigger than their controls (unpublished data). Considering that activation of Hh signaling can push adipocyte precursor cells toward an osteogenic fate at the expense of adipogenesis 10-13, 30, it is likely that Ptc1mice will display aberrant bone formation, which will affect the body weight during postnatal development. Recently, epidermal hyperplasia has been observed in adult Ptc1mice 18, which will likely be another factor to offset the reduced WAT weight. Nevertheless, it appears that white fat mass is not a major factor that directly contributes to the body weight gain during postnatal development. In conclusion, we found that Ptc1 was expressed in the epididymal fat pad of adult mice. Reduced total white fat mass and white adipose cell size were observed in adult Ptc1mice. Truncated Ptc1, Ptc2 and Gli1 were overexpressed in WAT of Ptc1, suggesting ectopic activation of Hh signaling in WAT. Consistent with reduced WAT, expression of adipogenic genes, PPARgamma and CEBPalpha, and adipocyte marker genes, aP2 and adipsin, were reduced in WAT of adult Ptc1 mice. Our results suggest that deletion of the carboxyl terminal tail of Ptc1 can lead to a reduction of white fat mass during postnatal development.
  29 in total

Review 1.  Transcriptional regulation of adipogenesis.

Authors:  E D Rosen; C J Walkey; P Puigserver; B M Spiegelman
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

Review 2.  Adipocyte differentiation from the inside out.

Authors:  Evan D Rosen; Ormond A MacDougald
Journal:  Nat Rev Mol Cell Biol       Date:  2006-12       Impact factor: 94.444

3.  Hedgehog signaling plays a conserved role in inhibiting fat formation.

Authors:  Jae Myoung Suh; Xiaohuan Gao; Jim McKay; Renee McKay; Zack Salo; Jonathan M Graff
Journal:  Cell Metab       Date:  2006-01       Impact factor: 27.287

4.  The C-terminal tail of the Hedgehog receptor Patched regulates both localization and turnover.

Authors:  Xingwu Lu; Songmei Liu; Thomas B Kornberg
Journal:  Genes Dev       Date:  2006-09-15       Impact factor: 11.361

Review 5.  Developmental origin of fat: tracking obesity to its source.

Authors:  Stephane Gesta; Yu-Hua Tseng; C Ronald Kahn
Journal:  Cell       Date:  2007-10-19       Impact factor: 41.582

6.  BMP-2 and sonic hedgehog have contrary effects on adipocyte-like differentiation of C3H10T1/2 cells.

Authors:  B K Zehentner; U Leser; H Burtscher
Journal:  DNA Cell Biol       Date:  2000-05       Impact factor: 3.311

7.  Epidermal hyperplasia and expansion of the interfollicular stem cell compartment in mutant mice with a C-terminal truncation of Patched1.

Authors:  Erica Nieuwenhuis; Paul C Barnfield; Shigeru Makino; Chi-Chung Hui
Journal:  Dev Biol       Date:  2007-06-26       Impact factor: 3.582

8.  Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation.

Authors:  S Spinella-Jaegle; G Rawadi; S Kawai; S Gallea; C Faucheu; P Mollat; B Courtois; B Bergaud; V Ramez; A M Blanchet; G Adelmant; R Baron; S Roman-Roman
Journal:  J Cell Sci       Date:  2001-06       Impact factor: 5.285

9.  In vivo functions of the patched protein: requirement of the C terminus for target gene inactivation but not Hedgehog sequestration.

Authors:  R L Johnson; L Milenkovic; M P Scott
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

10.  Regulation of pancreas development by hedgehog signaling.

Authors:  M Hebrok; S K Kim; B St Jacques; A P McMahon; D A Melton
Journal:  Development       Date:  2000-11       Impact factor: 6.868

View more
  12 in total

1.  Activation of Erk by sonic hedgehog independent of canonical hedgehog signalling.

Authors:  Hong Chang; Qing Li; Ricardo C Moraes; Michael T Lewis; Paul A Hamel
Journal:  Int J Biochem Cell Biol       Date:  2010-05-06       Impact factor: 5.085

2.  A contemporary atlas of the mouse diaphragm: myogenicity, vascularity, and the Pax3 connection.

Authors:  Pascal Stuelsatz; Paul Keire; Ricardo Almuly; Zipora Yablonka-Reuveni
Journal:  J Histochem Cytochem       Date:  2012-06-21       Impact factor: 2.479

3.  Altered metabolism and lipodystrophy in the early B-cell factor 1-deficient mouse.

Authors:  Jackie A Fretz; Tracy Nelson; Yougen Xi; Douglas J Adams; Clifford J Rosen; Mark C Horowitz
Journal:  Endocrinology       Date:  2010-02-19       Impact factor: 4.736

4.  Activities of the Cytoplasmic Domains of Patched-1 Modulate but Are Not Essential for the Regulation of Canonical Hedgehog Signaling.

Authors:  Andrew Fleet; Jennifer P Y Lee; Aaliya Tamachi; Imaan Javeed; Paul A Hamel
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

5.  A novel signaling pathway mediated by the nuclear targeting of C-terminal fragments of mammalian Patched 1.

Authors:  Hiroki Kagawa; Yuka Shino; Daigo Kobayashi; Syunsuke Demizu; Masumi Shimada; Hiroyoshi Ariga; Hiroyuki Kawahara
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

6.  Distinct effects of the mesenchymal dysplasia gene variant of murine Patched-1 protein on canonical and non-canonical Hedgehog signaling pathways.

Authors:  Malcolm C Harvey; Andrew Fleet; Nadia Okolowsky; Paul A Hamel
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

7.  The C-terminal cytoplasmic tail of hedgehog receptor Patched1 is a platform for E3 ubiquitin ligase complexes.

Authors:  Yuka Yamaki; Hiroki Kagawa; Tomohisa Hatta; Tohru Natsume; Hiroyuki Kawahara
Journal:  Mol Cell Biochem       Date:  2016-02-17       Impact factor: 3.396

8.  Overweight in mice and enhanced adipogenesis in vitro are associated with lack of the hedgehog coreceptor boc.

Authors:  Hye-Jin Lee; Shin-Bum Jo; Anthony I Romer; Hyo-Jeong Lim; Min-Jung Kim; Seung-Hoi Koo; Robert S Krauss; Jong-Sun Kang
Journal:  Diabetes       Date:  2015-01-09       Impact factor: 9.461

Review 9.  Molecular Mechanisms of Adipogenesis: The Anti-adipogenic Role of AMP-Activated Protein Kinase.

Authors:  Bilal Ahmad; Christopher J Serpell; Isabel Lim Fong; Eng Hwa Wong
Journal:  Front Mol Biosci       Date:  2020-05-08

10.  Lentivirus-mediated silencing of the PTC1 and PTC2 genes promotes recovery from spinal cord injury by activating the Hedgehog signaling pathway in a rat model.

Authors:  Ya-Dong Zhang; Zhong-Sheng Zhu; Dong Zhang; Zhen Zhang; Bin Ma; Shi-Chang Zhao; Feng Xue
Journal:  Exp Mol Med       Date:  2017-12-15       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.